Last updated: October 15, 2024
Sponsor: Loma Linda University
Overall Status: Active - Recruiting
Phase
3
Condition
N/ATreatment
Povidone-Iodine
Normal Saline
Clinical Study ID
NCT06363877
5220078
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 to 80 years of age
undergoing an exploratory laparotomy for Centers for Disease Control class II andIII wounds
Exclusion
Exclusion Criteria:
Pregnancy
Preoperative abdominal wall skin/soft tissue infection
Iodine allergy
Patients unlikely to survive beyond 30 days
Patients with mesh placement or placement of a foreign body except for drains
Study Design
Total Participants: 1100
Treatment Group(s): 2
Primary Treatment: Povidone-Iodine
Phase: 3
Study Start date:
June 03, 2024
Estimated Completion Date:
November 30, 2025
Study Description
Connect with a study center
Loma Linda University Health
Loma Linda, California 92354
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.